Skip to main content
. 2022 Oct 31;13:1020624. doi: 10.3389/fimmu.2022.1020624

Figure 4.

Figure 4

Inhibition of AKT abrogated the immunosuppressive action of SARS-CoV-2 S protein. A549 cells were treated with the pan-AKT inhibitor MK2206 (5μM) for 24 hours and then stimulated with SARS-CoV-2 S (50ng/ml) for 12 hours. Secretion of IL8 (A), IL6 (B) and TNFα (C) decreased in the presence of SARS-CoV-2 S, an effect which was less evident in MK2206-treated cells. Data are illustrated in bars and plotted as median with range (n=4 biological replicates per group). Statistical analysis was performed with Kruskal - Wallis test. *p < 0.05.